The Buck Institute for Research on Aging has entered into a partnership with Oracle to advance research into age-related diseases and the early detection of aging-related complications.
Under the collaboration, the institute will use Oracle Life Sciences Data Intelligence, a cloud-native analytics environment that combines owned, third-party, and real-world data with artificial intelligence capabilities for research hypothesis generation and analysis. As of May 2026, the platform contains more than 122 million de-identified longitudinal health records.
A central objective of the partnership is to support the development of what the Buck Institute describes as the first FDA-grade "intrinsic capacity score" for healthy aging. Researchers plan to analyze decades of longitudinal health records to identify clinical changes that signal the onset of frailty or chronic disease before symptoms appear, and to build models predicting which patients face the greatest risk of age-related decline.
The Buck Institute also acts as an analytics and bioinformatics contributor to the Stanford University-led THRIVE consortium, which operates under the PROSPR program run by the Advanced Research Projects Agency for Health (ARPA-H). ARPA-H is an agency within the U.S. Department of Health and Human Services, and the research is funded in part by the agency.
"Having the right solution and accessible patient data to aid in the study, discovery, and measurement of health span is essential," said Dr. David Furman of the Buck Institute.
The partnership was announced from Orlando, Fla., on Sept. 23, 2026.
